Alpha-1 antitrypsin: A potent anti-inflammatory and potential novel therapeutic agent

Archivum Immunologiae et Therapiae Experimentalis

Volumn 60, Issue 2, 2012, Pages 81-97

  Bergin, David A ^a   Hurley, Killian ^a   McElvaney, Noel G ^a   Reeves, Emer P ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Alpha 1 antitrypsin; Alpha 1 antitrypsin deficiency; Innate immune cells; Replacement therapy

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIINFLAMMATORY AGENT; DOXYCYCLINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOCYTE ELASTASE; LEUKOTRIENE B4; MACROPHAGE ELASTASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIINFLAMMATORY ACTIVITY; CELL FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DRUG POTENCY; EMPHYSEMA; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; LUNG DISEASE; LYMPHOCYTE MIGRATION; NONHUMAN; PANNICULITIS; REVIEW; RHEUMATOID ARTHRITIS; VASCULITIS; VIRUS INFECTION;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL MOVEMENT; HUMANS; IMMUNITY, INNATE; LUNG DISEASES; NEUTROPHILS; SIGNAL TRANSDUCTION;

EID: 84858705230     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-012-0162-5     Document Type: Review

References (170)

1. Abboud RT, Ford GT, Chapman KR (2001) Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society. Can Respir J 8(2):81-88 (Pubitemid 32496355)
2. Ahn CM, Sandler H, Glass M, Saldeen T (1993) Effect of a synthetic leukocyte elastase inhibitor on thrombin-induced pulmonary edema in the rat. Exp Lung Res 19(2):125-135 (Pubitemid 23114016)
3. Al-Niaimi F, Lyon C (2011) Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: remission induced and maintained with intravenous alpha 1-antitrypsin. J Am Acad Dermatol 65(1):227-229
4. Al-Omari M, Korenbaum E, Ballmaier M, Lehmann U, Jonigk D, Manstein DJ, Welte T, Mahadeva R, Janciauskiene S (2011) The acute phase protein, alpha1-antitrypsin, inhibits neutrophil calpain I and induces random migration. Mol Med 17(9-10):865-874
5. Aoshiba K, Nagai A, Takizawa T (1991) Effects of proteinase inhibitors on polymorphonuclear neutrophil polarization. Tohoku J Exp Med 165(3):165-170
6. Ballou SP, Lozanski G (1992) Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4(5):361-368
7. Barnett VT, Sekosan M, Khurshid A (1999) Wegener's granulomatosis and alpha1-antitrypsin-deficiency emphysema: proteinaserelated diseases. Chest 116(1):253-255 (Pubitemid 29340293)
8. Baslund B, Petersen J, Permin H, Wiik A, Wieslander J (1994) Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma. J Immunol Methods 175(2):215-225 (Pubitemid 24323994)
9. Beatty K, Bieth J, Travis J (1980) Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J Biol Chem 255(9):3931-3934
10. Berger M, Sorensen RU, Tosi MF, Dearborn DG, Doring G (1989) Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 84(4):1302-1313 (Pubitemid 19247604)
11. Bergin DA, Reeves EP, Meleady P, Henry M, McElvaney OJ, Carroll TP, Condron C, Chotirmall SH, Clynes M, O'Neill SJ, McElvaney NG (2010) Alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J Clin Invest 120(12):4236-4250
12. Birrer P, McElvaney NG, Rudeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG (1994) Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med 150(1):207-213 (Pubitemid 24209960)
13. Bjork I, Nordling K, Larsson I, Olson ST (1992) Kinetic characterization of the substrate reaction between a complex of antithrombin with a synthetic reactive-bond loop tetradecapeptide and four target proteinases of the inhibitor. J Biol Chem 267(27):19047-19050
14. Blanco I, Beritze N, Arguelles M, Carcaba V, Fernandez F, Janciauskiene S, Oikonomopoulou K, de Serres FJ, Fernandez- Bustillo E, Hollenberg MD (2010a) Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol 29(12):1403-1412
15. Blanco I, Canto H, de Serres FJ, Fernandez-Bustillo E, Rodriguez MC (2004) Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency. J Rheumatol 31(10):2082-2085 (Pubitemid 39336741)
16. Blanco I, Canto H, Flores J, Camblor C, Carcaba V, de Serres FJ, Janciauskiene S, Bustillo EF (2008) Long-term augmentation therapy with alpha-1 antitrypsin in an MZ-AAT severe persistent asthma. Monaldi Arch Chest Dis 69(4):178-182
17. Blanco I, Janciauskiene S, Nita I, Fernandez-Bustillo E, Carcaba V, Gallo C, Alvarez-Rico M, de Serres F, Beridze N (2010b) Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNFalpha), and vascular endothelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgia. Clin Rheumatol 29(2):189-197
18. Blanco I, Lara B, de Serres F (2011) Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis 6:14
19. Bosco D, Meda P, Morel P, Matthey-Doret D, Caille D, Toso C, Buhler LH, Berney T (2005) Expression and secretion of alpha1-proteinase inhibitor are regulated by proinflammatory cytokines in human pancreatic islet cells. Diabetologia 48(8):1523-1533 (Pubitemid 41175505)
20. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM (1974) Modulation of inflammation and immunity by cyclic AMP. Science 184(132):19-28
21. Boutten A, Dehoux M, Deschenes M, Rouzeau JD, Bories PN, Durand G (1992) Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol 22(10):2687-2695
22. Boutten A, Venembre P, Seta N, Hamelin J, Aubier M, Durand G, Dehoux MS (1998) Oncostatin M is a potent stimulator of alpha1-antitrypsin secretion in lung epithelial cells: modulation by transforming growth factor-beta and interferon-gamma. Am J Respir Cell Mol Biol 18(4):511-520 (Pubitemid 128353624)
23. Brand P, Schulte M, Wencker M, Herpich CH, Klein G, Hanna K, Meyer T (2009) Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J 34(2):354-360
24. Brantly M, Nukiwa T, Crystal RG (1988) Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 84(6A):13-31
25. Brennan S (2007) Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise? Eur Respir J 29(2):229-230
26. Bucurenci N, Blake DR, Chidwick K, Winyard PG (1992) Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett 300(1):21-24
27. Campos MA, Alazemi S, Zhang G, Wanner A, Salathe M, Baier H, Sandhaus RA (2009) Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy. Respir Med 103(10):1532-1539
28. Cantin AM, Woods DE (1999) Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am J Respir Crit Care Med 160(4):1130-1135 (Pubitemid 29487450)
29. Carroll TP, Greene CM, O'Connor CA, Nolan AM, O'Neill SJ, McElvaney NG (2010) Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency. J Immunol 184(8):4538-4546
30. Cella G, Bellotto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120(4):1226-1230 (Pubitemid 32960098)
31. Chan ED, Kaminska AM, Gill W, Chmura K, Feldman NE, Bai X, Floyd CM, Fulton KE, Huitt GA, Strand MJ, Iseman MD, Shapiro L (2007) Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand J Infect Dis 39(8):690-696 (Pubitemid 47189022)
32. Chang WS, Wardell MR, Lomas DA, Carrell RW (1996) Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem J 314(Pt 2):647-653 (Pubitemid 26074781)
33. Chapman KR, Stockley RA, Dawkins C, Wilkes MM, Navickis RJ (2009) Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD 6(3):177-184
34. Chen XL, Zhou L, Yang J, Shen FK, Zhao SP, Wang YL (2010) Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS. Mol Med Report 3(4):589-596
35. Chen ZQ, He SH (2004) Cloning and expression of human colon mast cell carboxypeptidase. World J Gastroenterol 10(3):342-347
36. Chowdhury MM, Williams EJ, Morris JS, Ferguson BJ, McGregor AD, Hedges AR, Stamatakis JD, Pope FM (2002) Severe panniculitis caused by homozygous ZZ alpha1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin). Br J Dermatol 147(6):1258-1261 (Pubitemid 36963038)
37. Churg A, Wang RD, Xie C, Wright JL (2003) Alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 168(2):199-207 (Pubitemid 36920974)
38. Churg A, Wang X, Wang RD, Meixner SC, Pryzdial EL, Wright JL (2007) Alpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophages. Am J Respir Cell Mol Biol 37(2):144-151 (Pubitemid 47254997)
39. Cichy J, Potempa J, Travis J (1997) Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem 272(13):8250-8255 (Pubitemid 27147779)
40. Clemmensen I, Christensen F (1976) Inhibition of urokinase by complex formation with human alpha1-antitrypsin. Biochim Biophys Acta 429(2):591-599
41. Cox DW, Huber O (1976) Rheumatoid arthritis and alpha-1-antitrypsin. Lancet 1(7971):1216-1217
42. Cox DW, Huber O (1980) Association of severe rheumatoid arthritis with heterozygosity for alpha 1-antitrypsin deficiency. Clin Genet 17(2):153-160 (Pubitemid 10155010)
43. Crystal RG (1990) Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 85(5):1343-1352
44. Curiel DT, Chytil A, Courtney M, Crystal RG (1989) Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264-Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion. J Biol Chem 264(18):10477-10486 (Pubitemid 19161612)
45. Daemen MA, Heemskerk VH, van't Veer C, Denecker G, Wolfs TG, Vandenabeele P, Buurman WA (2000) Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 102(12):1420-1426
46. de Serres FJ, Blanco I, Fernandez-Bustillo E (2007) PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Monaldi Arch Chest Dis 67(4):184-208 (Pubitemid 351188320)
47. Dhami R, Gilks B, Xie C, Zay K, Wright JL, Churg A (2000) Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin. Am J Respir Cell Mol Biol 22(2):244-252 (Pubitemid 30351488)
48. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DC, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, Vrooman HA, Reiber JH, Hansen NC, Heckscher T, Viskum K, Stolk J (1999) A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 160(5 Pt 1):1468-1472
49. Dirksen A, Piitulainen E, Parr DG, Deng C, Wencker M, Shaker SB, Stockley RA (2009) Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur Respir J 33(6):1345-1353
50. Dobrinich R, Spagnuolo PJ (1991) Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst activity. Arthritis Rheum 34(8):1031-1038
51. Dowd SK, Rodgers GC, Callen JP (1995) Effective treatment with alpha 1-protease inhibitor of chronic cutaneous vasculitis associated with alpha 1-antitrypsin deficiency. J Am Acad Dermatol 33(5 Pt 2):913-916
52. du Bois RM, Bernaudin JF, Paakko P, Hubbard R, Takahashi H, Ferrans V, Crystal RG (1991) Human neutrophils express the alpha 1-antitrypsin gene and produce alpha 1-antitrypsin. Blood 77(12):2724-2730
53. Duranton J, Bieth JG (2003) Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo. Am J Respir Cell Mol Biol 29(1):57-61 (Pubitemid 36783316)
54. Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist AS, Fallat RJ, Stoller JK, Crystal RG, Turino GM (2003) Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest 123(3):765-771 (Pubitemid 36315491)
55. Eden E, Strange C, Holladay B, Xie L (2006) Asthma and allergy in alpha-1 antitrypsin deficiency. Respir Med 100(8):1384-1391 (Pubitemid 43942327)
56. Elzouki AN, Segelmark M, Wieslander J, Eriksson S (1994) Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J Intern Med 236(5):543-548
57. Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 314(12):736-739 (Pubitemid 16124387)
58. Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, Sesboue R, Martin JP, Lesavre P (1993) Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 43(6):1329-1332 (Pubitemid 23161420)
59. Fernandez-Torres R, Garcia-Silva J, Robles O, Otero A, Vazquez MA, Fonseca E (2009) Alfa-1-antitrypsin deficiency panniculitis acquired after liver transplant and successfully treated with retransplant. J Am Acad Dermatol 60(4):715-716
60. Fitton HL, Pike RN, Carrell RW, Chang WS (1997) Mechanisms of antithrombin polymerisation and heparin activation probed by the insertion of synthetic reactive loop peptides. Biol Chem 378(9):1059-1063 (Pubitemid 27438029)
61. Forney JR, Yang S, Healey MC (1997a) Antagonistic effect of human alpha-1-antitrypsin on excystation of Cryptosporidium parvum oocysts. J Parasitol 83(4):771-774 (Pubitemid 27357539)
62. Forney JR, Yang S, Healey MC (1997b) Synergistic anticryptosporidial potential of the combination alpha-1-antitrypsin and paromomycin. Antimicrob Agents Chemother 41(9):2006-2008 (Pubitemid 27383245)
63. Fregonese L, Stolk J, Frants RR, Veldhuisen B (2008) Alpha-1 antitrypsin Null mutations and severity of emphysema. Respir Med 102(6):876-884
64. Gallimore MJ (1975) Serum inhibitors in fibrinolysis. Br J Haematol 31(2):217-231
65. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL et al (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370(6490):555-557 (Pubitemid 24264920)
66. Geller DE, Kesser KC (2010) The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation. J Aerosol Med Pulm Drug Deliv 23(Suppl 1):S55-S59
67. Geraghty P, Rogan MP, Greene CM, Brantly ML, O'Neill SJ, Taggart CC, McElvaney NG (2008) Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro. Thorax 63(7):621-626 (Pubitemid 351969256)
68. Gibbons AM, McElvaney NG, Taggart CC, Cryan SA (2009) Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation. J Microencapsul 26(6):513-522
69. Gossage JR, Kuratomi Y, Davidson JM, Lefferts PL, Snapper JR (1993) Neutrophil elastase inhibitors, SC-37698 and SC-39026, reduce endotoxin-induced lung dysfunction in awake sheep. Am Rev Respir Dis 147(6 Pt 1):1371-1379 (Pubitemid 23160531)
70. Gottlieb DJ, Luisetti M, Stone PJ, Allegra L, Cantey-Kiser JM, Grassi C, Snider GL (2000) Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group. Am J Respir Crit Care Med 162(6):2069-2072 (Pubitemid 32051666)
71. Greene CM, Miller SD, Carroll T, McLean C, O'Mahony M, Lawless MW, O'Neill SJ, Taggart CC, McElvaney NG (2008) Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. J Inherit Metab Dis 31(1):21-34
72. Griese M, Latzin P, Kappler M, Weckerle K, Heinzlmaier T, Bernhardt T, Hartl D (2007) Alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur Respir J 29(2):240-250 (Pubitemid 46231900)
73. Grimstein C, Choi YK, Satoh M, Lu Y, Wang X, Campbell- Thompson M, Song S (2010a) Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis. J Gene Med 12(1):35-44
74. Grimstein C, Choi YK, Wasserfall CH, Satoh M, Atkinson MA, Brantly ML, Campbell-Thompson M, Song S (2010b) Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. J Transl Med 9:21
75. Gross B, Grebe M, Wencker M, Stoller JK, Bjursten LM, Janciauskiene S (2009) New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology 218(4):370-375
76. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, Roscher AA, Roos D, Griese M (2007) Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 13(12):1423-1430 (Pubitemid 350224252)
77. He SH, Xie H, Zhang XJ, Wang XJ (2004) Inhibition of histamine release from human mast cells by natural chymase inhibitors. Acta Pharmacol Sin 25(6):822-826 (Pubitemid 38736112)
78. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG (1991) Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 88(3):891-897
79. Hubbard RC, McElvaney NG, Sellers SE, Healy JT, Czerski DB, Crystal RG (1989) Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency. J Clin Invest 84(4):1349-1354 (Pubitemid 19247611)
80. Iba T, Kidokoro A, Fukunaga M, Takuhiro K, Yoshikawa S, Sugimotoa K (2006) Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters. Shock 26(1):95-98 (Pubitemid 44297012)
81. Janciauskiene S, Larsson S, Larsson P, Virtala R, Jansson L, Stevens T (2004) Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin. Biochem Biophys Res Commun 321(3):592-600 (Pubitemid 39118381)
82. Janciauskiene S, Nita I, Subramaniyam D, Li Q, Lancaster JR Jr, Matalon S (2008) Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro. Am J Respir Cell Mol Biol 39(6):631-637
83. Janciauskiene SM, Nita IM, Stevens T (2007) Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem 282(12):8573-8582 (Pubitemid 47093518)
84. Jie Z, Cai Y, Yang W, Jin M, Zhu W, Zhu C (2003) Protective effects of alpha 1-antitrypsin on acute lung injury in rabbits induced by endotoxin. Chin Med J (Engl) 116(11):1678-1682 (Pubitemid 38008236)
85. Johansson B, Malm J, Persson T, Janciauskiene S, Andersson P, Carlson J, Egesten A (2001) Alpha-1-antitrypsin is present in the specific granules of human eosinophilic granulocytes. Clin Exp Allergy 31(3):379-386 (Pubitemid 34204157)
86. Kakimoto K, Matsukawa A, Yoshinaga M, Nakamura H (1995) Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Cell Immunol 165(1):26-32
87. Kalis M, Kumar R, Janciauskiene S, Salehi A, Cilio CM (2010) Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells. Islets 2(3):185-189
88. Kalsheker N, Morley S, Morgan K (2002) Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans 30(2):93-98
89. Karoli NA, Rebrov AP, Iudakova Iu N (2004) Vascular endothelial dysfunction in patients with chronic obstructive lung diseases. Probl Tuberk Bolezn Legk 4:19-23
90. Kawabata K, Hagio T, Matsumoto S, Nakao S, Orita S, Aze Y, Ohno H (2000) Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am J Respir Crit Care Med 161(6):2013-2018 (Pubitemid 30418145)
91. Kilpatrick L, McCawley L, Nachiappan V, Greer W, Majumdar S, Korchak HM, Douglas SD (1992) Alpha-1-antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. J Immunol 149(9):3059-3065
92. Knappstein S, Ide T, Schmidt MA, Heusipp G (2004) Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains. Infect Immun 72(8):4344-4350 (Pubitemid 38989289)
93. Knoell DL, Ralston DR, Coulter KR, Wewers MD (1998) Alpha 1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha in monocytes. Am J Respir Crit Care Med 157(1):246-255 (Pubitemid 28071289)
94. Koczulla R, Bittkowski N, Andress J, Greulich T, Schroth S, Kotke V, Vogelmeier C, Bals R (2008) The German registry of individuals with alpha-1-antitrypsin deficiency: a source for research on patient care. Pneumologie 62(11):655-658
95. Kolarich D, Turecek PL, Weber A, Mitterer A, Graninger M, Matthiessen P, Nicolaes GA, Altmann F, Schwarz HP (2006a) Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy. Transfusion 46(11):1959-1977 (Pubitemid 44631604)
96. Kolarich D, Weber A, Turecek PL, Schwarz HP, Altmann F (2006b) Comprehensive glyco-proteomic analysis of human alpha1-antitrypsin and its charge isoforms. Proteomics 6(11):3369-3380 (Pubitemid 43886153)
97. Kunkel SL, Spengler M, May MA, Spengler R, Larrick J, Remick D (1988) Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263(11):5380-5384
98. Laine E, Couderc R, Roch-Arveiller M, Vasson MP, Giroud JP, Raichvarg D (1990) Modulation of human polymorphonuclear neutrophil functions by alpha 1-acid glycoprotein. Inflammation 14(1):1-9 (Pubitemid 20061415)
99. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA (2005) Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA 102(34):12153-12158 (Pubitemid 41291144)
100. Lhotta K, Vogel W, Meisl T, Buxbaum M, Neyer U, Sandholzer C, Konig P (1994) Alpha 1-antitrypsin phenotypes in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis. Clin Sci (Lond) 87(6):693-695 (Pubitemid 24374000)
101. Libert C, Van Molle W, Brouckaert P, Fiers W (1996) alpha1-Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 157(11):5126-5129 (Pubitemid 126449595)
102. Lieberman J (2000) Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest 118(5):1480-1485
103. Lindhout T, Iqbal U, Willis LM, Reid AN, Li J, Liu X, Moreno M, Wakarchuk WW (2011) Site-specific enzymatic polysialylation of therapeutic proteins using bacterial enzymes. Proc Natl Acad Sci USA 108(18):7397-7402
104. Liqun Wang R, McLaughlin T, Cossette T, Tang Q, Foust K, Campbell-Thompson M, Martino A, Cruz P, Loiler S, Mueller C, Flotte TR (2009) Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery. Mol Ther 17(1):81-87
105. Lomas DA, Evans DL, Finch JT, Carrell RW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357(6379):605-607
106. Lu Y, Tang M, Wasserfall C, Kou Z, Campbell-Thompson M, Gardemann T, Crawford J, Atkinson M, Song S (2006) Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum Gene Ther 17(6):625-634 (Pubitemid 43967866)
107. Luo LY, Jiang W (2006) Inhibition profiles of human tissue kallikreins by serine protease inhibitors. Biol Chem 387(6):813-816
108. Lushbaugh WB, Kairalla AB, Hofbauer AF, Arnaud P, Cantey JR, Pittman FE (1981) Inhibition of Entamoeba histolytica cytotoxin by alpha 1 antiprotease and alpha 2 macroglobulin. Am J Trop Med Hyg 30(3):575-585 (Pubitemid 11074935)
109. Mahrus S, Kisiel W, Craik CS (2004) Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B. J Biol Chem 279(52):54275-54282 (Pubitemid 40053165)
110. Malerba M, Ricciardolo F, Radaeli A, Torregiani C, Ceriani L, Mori E, Bontempelli M, Tantucci C, Grassi V (2006) Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects. Thorax 61(2):129-133 (Pubitemid 43235429)
111. Martin SL, Downey D, Bilton D, Keogan MT, Edgar J, Elborn JS (2006) Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. Pediatr Pulmonol 41(2):177-183 (Pubitemid 43165448)
112. Mast AE, Enghild JJ, Pizzo SV, Salvesen G (1991) Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 30(6):1723-1730
113. McCarthy C, Dimitrov BD (2010) Augmentation therapy for alpha-1 antitrypsin deficiency-not enough evidence to support its use yet! COPD 7(3):234 (author reply 235-236)
114. McElvaney NG, Crystal RG (1997) Proteases and lung injury. In: Crystal RG, West JB, Weibel ER, Barnes PJ (eds) The lung: scientific foundations. Raven Press Inc, New York, pp 2205-2219
115. McElvaney NG, Hubbard RC, Birrer P, Chernick MS, Caplan DB, Frank MM, Crystal RG (1991) Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet 337(8738):392-394
116. McElvaney NG, Nakamura H, Birrer P, Hebert CA, Wong WL, Alphonso M, Baker JB, Catalano MA, Crystal RG (1992) Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 90(4):1296-1301
117. McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7(6):429-442 (Pubitemid 46834849)
118. Miyamoto Y, Akaike T, Alam MS, Inoue K, Hamamoto T, Ikebe N, Yoshitake J, Okamoto T, Maeda H (2000a) Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity. Biochem Biophys Res Commun 267(3):918-923 (Pubitemid 30099423)
119. Miyamoto Y, Akaike T, Maeda H (2000b) S-nitrosylated human alpha(1)-protease inhibitor. Biochim Biophys Acta 1477(1-2):90-97
120. Molano RD, Pileggi A, Song S, Zahr E, San Jose S, Molina J, Fort A, Wasserfall C, Ricordi C, Atkinson MA, Inverardi L (2008) Prolonged islet allograft survival by alpha-1 antitrypsin: the role of humoral immunity. Transplant Proc 40(2):455-456 (Pubitemid 351419222)
121. Molmenti EP, Perlmutter DH, Rubin DC (1993) Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium. J Clin Invest 92(4):2022-2034 (Pubitemid 23304573)
122. Mulgrew AT, Taggart CC, Lawless MW, Greene CM, Brantly ML, O'Neill SJ, McElvaney NG (2004) Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 125(5):1952-1957 (Pubitemid 38648435)
123. Munch J, Standker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pohlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F (2007) Discovery and optimization of a natural HIV- 1 entry inhibitor targeting the gp41 fusion peptide. Cell 129(2):263-275 (Pubitemid 46574967)
124. Nagai A, Aoshiba K, Ishihara Y, Inano H, Sakamoto K, Yamaguchi E, Kagawa J, Takizawa T (1992) Administration of alpha 1-proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis 145(3):651-656
125. Needham M, Stockley RA (2005) Exacerbations in {alpha}1-antitrypsin deficiency. Eur Respir J 25(6):992-1000
126. Nicholls MG, Janus ED (1973) Hashimoto's thyroiditis and homozygous alpha 1-antitrypsin deficiency. Aust N Z J Med 3(5):516-519
127. Nita IM, Serapinas D, Janciauskiene SM (2007) alpha1-Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro. Int J Biochem Cell Biol 39(6):1165-1176 (Pubitemid 46819133)
128. Ollivier V, Parry GC, Cobb RR, de Prost D, Mackman N (1996) Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271(34):20828-20835 (Pubitemid 26281870)
129. Ouagued M, Martin-Chouly CA, Brinchault G, Leportier-Comoy C, Depince A, Bertrand C, Lagente V, Belleguic C, Pruniaux MP (2005) The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients. Pulm Pharmacol Ther 18(1):49-54 (Pubitemid 39647753)
130. Palma-Carlos AG, Palma-Carlos ML (2007) Alpha-1-antitrypsin deficiency asthma and allergy. Eur Ann Allergy Clin Immunol 39(4):127-132
131. Panyutich AV, Hiemstra PS, van Wetering S, Ganz T (1995) Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol 12(3):351-357
132. Parmar JS, Mahadeva R, Reed BJ, Farahi N, Cadwallader KA, Keogan MT, Bilton D, Chilvers ER, Lomas DA (2002) Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 26(6):723-730 (Pubitemid 34557374)
133. Patston PA, Roodi N, Schifferli JA, Bischoff R, Courtney M, Schapira M (1990) Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems. J Biol Chem 265(18):10786-10791
134. Perlmutter DH (2002) Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest 110(11):1579-1583
135. Perlmutter DH (2004) Alpha-1-antitrypsin deficiency: diagnosis and treatment. Clin Liver Dis 8(4):839-859 (viii-ix)
136. Perlmutter DH, Schlesinger MJ, Pierce JA, Punsal PI, Schwartz AL (1989) Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease. J Clin Invest 84(5):1555-1561 (Pubitemid 19272244)
137. Perlmutter DH, Travis J, Punsal PI (1988) Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency. J Clin Invest 81(6):1774-1780
138. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM (2006) Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 169(4):1155-1166 (Pubitemid 351194353)
139. Pileggi A, Molano RD, Song S, Zahr E, SanJose S, Villate S, Wasserfall C, Ricordi C, Atkinson MA, Inverardi L (2008) Alpha-1 antitrypsin treatment of spontaneously diabetic nonobese diabetic mice receiving islet allografts. Transplant Proc 40(2):457-458 (Pubitemid 351419223)
140. Reeves EP, Cosgrove S, Bergin DA, Greene CM, McElvaney NG (2010) New strategies in drug development focusing on the antiprotease- protease balance in alpha-1 antitrypsin deficiency. Anti- Inflammatory and Anti-Allergy Agents in Medicinal Chemistry 9:314-329
141. Rogers J, Kalsheker N, Wallis S, Speer A, Coutelle CH, Woods D, Humphries SE (1983) The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes. Biochem Biophys Res Commun 116(2):375-382 (Pubitemid 14242761)
142. Rooney CP, Taggart C, Coakley R, McElvaney NG, O'Neill SJ (2001) Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin. Am J Respir Cell Mol Biol 24(6):747-754 (Pubitemid 32550598)
143. Rouhani F, Paone G, Smith NK, Krein P, Barnes P, Brantly ML (2000) Lung neutrophil burden correlates with increased proinflammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiency. Chest 117(5 Suppl 1):250S-251S (Pubitemid 30326977)
144. Sandhaus RA, Turino G, Stocks J, Strange C, Trapnell BC, Silverman EK, Everett SE, Stoller JK (2008) Alpha1-Antitrypsin augmentation therapy for PI*MZ heterozygotes: a cautionary note. Chest 134(4):831-834
145. Sandstrom C, Piitulainen E, Janciauskiene S (2008a) Augmentation therapy in emphysema patient with ZZ a-1-antitrypsin deficiency. Respiratory Medicine CME 1:153-157
146. Sandstrom CS, Ohlsson B, Melander O, Westin U, Mahadeva R, Janciauskiene S (2008b) An association between Type 2 diabetes and alpha-antitrypsin deficiency. Diabet Med 25(11):1370-1373
147. Seersholm N, Wencker M, Banik N, Viskum K, Dirksen A, Kok-Jensen A, Konietzko N (1997) Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. Eur Respir J 10(10):2260-2263
148. Segelmark M, Elzouki AN, Wieslander J, Eriksson S (1995) The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3- ANCA-positive vasculitis. Kidney Int 48(3):844-850
149. Simpson AJ, Cunningham GA, Porteous DJ, Haslett C, Sallenave JM (2001) Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide. Hum Gene Ther 12(11):1395-1406 (Pubitemid 32881345)
150. Sohrab S, Petrusca DN, Lockett AD, Schweitzer KS, Rush NI, Gu Y, Kamocki K, Garrison J, Petrache I (2009) Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium. FASEB J 23(9):3149-3158
151. Song S, Goudy K, Campbell-Thompson M, Wasserfall C, Scott-Jorgensen M, Wang J, Tang Q, Crawford JM, Ellis TM, Atkinson MA, Flotte TR (2004) Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther 11(2):181-186 (Pubitemid 38159690)
152. Spencer LT, Paone G, Krein PM, Rouhani FN, Rivera-Nieves J, Brantly ML (2004) Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol 286(3):L514-L520 (Pubitemid 38233622)
153. Stockley RA, Bayley DL, Unsal I, Dowson LJ (2002) The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 165(11):1494-1498 (Pubitemid 34606663)
154. Stockley RA, Shaw J, Afford SC, Morrison HM, Burnett D (1990) Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis. Am J Respir Cell Mol Biol 2(2):163-170
155. Subramaniyam D, Steele C, Kohnlein T, Welte T, Grip O, Matalon S, Janciauskiene S (2010) Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo. Inflamm Res 59(7):571-578
156. Subramaniyam D, Virtala R, Pawlowski K, Clausen IG, Warkentin S, Stevens T, Janciauskiene S (2008) TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int J Biochem Cell Biol 40(2):258-271 (Pubitemid 350137878)
157. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, Levine RL (2000) Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of antineutrophil elastase activity. J Biol Chem 275(35):27258-27265
158. The Alpha-1-Antitrypsin Deficiency Registry Study Group (1998) Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. Am J Respir Crit Care Med 158:49-59
159. Tonelli AR, Rouhani F, Li N, Schreck P, Brantly ML (2009) Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank. Int J Chron Obstruct Pulmon Dis 4:443-452
160. Tuder RM, Janciauskiene SM, Petrache I (2010) Lung disease associated with alpha1-antitrypsin deficiency. Proc Am Thorac Soc 7(6):381-386
161. Turino GM, Barker AF, Brantly ML, Cohen AB, Connelly RP, Crystal RG, Eden E, Schluchter MD, Stoller JK (1996) Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency. alpha 1-Antitrypsin Deficiency Registry Study Group. Am J Respir Crit Care Med 154(6 Pt 1):1718-1725 (Pubitemid 26424941)
162. van Pel M, van Os R, Velders GA, Hagoort H, Heegaard PM, Lindley IJ, Willemze R, Fibbe WE (2006) Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci USA 103(5):1469-1474 (Pubitemid 43191189)
163. Venembre P, Boutten A, Seta N, Dehoux MS, Crestani B, Aubier M, Durand G (1994) Secretion of alpha 1-antitrypsin by alveolar epithelial cells. FEBS Lett 346(2-3):171-174
164. Ward PA, Talamo RC (1973) Deficiency of the chemotactic factor inactivator in human sera with 1 -antitrypsin deficiency. J Clin Invest 52(2):516-519
165. Warter J, Storck D, Grosshans E, Metais P, Kuntz JL, Klumpp T (1972) Weber-Christian syndrome associated with an alpha-1 antitrypsin deficiency. Familial investigation. Ann Med Interne (Paris) 123(10):877-882
166. Wencker M, Brantly ML (2005) Cytotoxic concentrations of alphadefensins in the lungs of individuals with alpha 1-antitrypsin deficiency and moderate to severe lung disease. Cytokine 32(1):1-6 (Pubitemid 41405777)
167. Wencker M, Fuhrmann B, Banik N, Konietzko N (2001) Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 119(3):737-744 (Pubitemid 32197642)
168. Yasui S, Nagai A, Aoshiba K, Ozawa Y, Kakuta Y, Konno K (1995) A specific neutrophil elastase inhibitor (ONO-5046.Na) attenuates LPS-induced acute lung inflammation in the hamster. Eur Respir J 8(8):1293-1299
169. Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, Atkinson M, Song S (2007) Alpha1-antitrypsin protects betacells from apoptosis. Diabetes 56(5):1316-1323
170. Zhou X, Shapiro L, Fellingham G, Willardson BM, Burton GF (2010) HIV replication in CD4 + T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by alpha-1-antitrypsin through altered IkappaBalpha ubiquitination. J Immunol 186(5):3148-3155